Xiangsha Yangwei Pills
Natural health product licensed in Canada
- Other names
- Xiangsha Yangwei Wan
- Licence holder
- Jilin Aoyuan Medicine Technology Co. LTD.
- NPN or DIN-HM
- 80144895
- Status
- Active licence
- Licence date
- 21 October 2025
- Revision date
- 13 November 2025
- Form
- Pilule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
- Conditions légales
Cyperus rotundus L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes et allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Citrus aurantium L.: La quantité ingérée de p-synéphrine doit être inférieure à 20 mg par dose journalière recommandée. L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants, aux femmes enceintes ou allaitantes et en cas de traitement anti-hypertenseur. La caféine et les sources de caféine ne sont pas autorisées dans les compléments alimentaires contenant Citrus aurantium L.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Glycyrrhiza glabra L.: La portion journalière recommandée ne doit pas conduire à une ingestion d'acide glycyrrhizinique supérieure à 100 mg. L'étiquetage doit comporter un avertissement avec la teneur suivante: "Ne pas utiliser pendant plus de 6 semaines sans avis médical." L'étiquetage doit comporter un avertissement déconseillant l'emploi chez les enfants.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Magnolia officinalis Rehder & E.H.Wilson: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Zingiber officinale Source : Zingiber officinale - Rhizome Extract : Matériel brut sec Extraction ratio : 3:1 Dry plant equivalent : 11.4 mg | 3.8 mg | Not calculated |
| Amomum villosum Source : Amomum villosum - Fruit Extract : Matériel brut sec Extraction ratio : 3.018:1 Dry plant equivalent : 33.8 mg | 11.2 mg | Not calculated |
| Pinellia ternata Source : Pinellia ternata - Rhizome Extract : Matériel brut sec Extraction ratio : 3.013:1 Dry plant equivalent : 113 mg | 37.5 mg | Not calculated |
| Cyperus rotundus Extract : Matériel brut sec Extraction ratio : 3.018:1 Dry plant equivalent : 33.8 mg | 11.2 mg | Not calculated |
| Citrus aurantium Source : Citrus aurantium - fruit Extract : Matériel brut sec Extraction ratio : 3.018:1 Dry plant equivalent : 33.8 mg | 11.2 mg | Not calculated |
| Saussurea costus Extract : Matériel brut sec Extraction ratio : 3.013:1 Dry plant equivalent : 226 mg | 75 mg | Not calculated |
| Atractylodes macrocephala Extract : Matériel brut sec Extraction ratio : 3.013:1 Dry plant equivalent : 226 mg | 75 mg | Not calculated |
| Citrus reticulata Extract : Matériel brut sec Extraction ratio : 3.013:1 Dry plant equivalent : 113 mg | 37.5 mg | Not calculated |
| Amomum krervanh Source : Amomum krervanh - Fruit Extract : Matériel brut sec Extraction ratio : 3.018:1 Dry plant equivalent : 33.8 mg | 11.2 mg | Not calculated |
| Wolfiporia extensa Extract : Matériel brut sec Extraction ratio : 3.014:1 Dry plant equivalent : 169.4 mg | 56.2 mg | Not calculated |
| Glycyrrhiza glabra Extract : Matériel brut sec Extraction ratio : 3.016:1 Dry plant equivalent : 56.4 mg | 18.7 mg | Not calculated |
| Pogostemon cablin Extract : Matériel brut sec Extraction ratio : 3:1 Dry plant equivalent : 45 mg | 15 mg | Not calculated |
| Ziziphus jujuba Source : Ziziphus jujuba - Fruit Extract : Matériel brut sec Extraction ratio : 3:1 Dry plant equivalent : 11.4 mg | 3.8 mg | Not calculated |
| Magnolia officinalis Extract : Matériel brut sec Extraction ratio : 3:1 Dry plant equivalent : 45 mg | 15 mg | Not calculated |
Non-medicinal ingredients
Sirop de malt
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 8 Pilule | 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Combination of Traditional Chinese Medicine Ingredients. Remedy/Product/Preparation based on the theory of Traditional Chinese Medicine.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80144895
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.